Precedential US Federal Court Decision Hands SNIPR a win in patent appeal over Rockefeller University for CRISPR-Cas microbial gene editing

Five contested patents held by SNIPR remain in place.

Precedential ruling means that SNIPR’s patent portfolio will not be subject to any further interference and will not be judged by the old first-to-invent standard.

Press release

US court opinion

US court decision

Law360 article

Previous
Previous

SNIPR receives USD 5.48 million funding from CARB-X to support advancement of CRISPR-medicine SNIPR001 into clinical trials

Next
Next

SNIPR has research findings published in Nature Biotechnology